Skip to content

Application Effect of Ultrasound-Guided Dual-Tunnel PICC Catheterization via Axillary Vein in Hematological Oncology Patients

Application Effect of Ultrasound-Guided Dual-Tunnel PICC Catheterization via Axillary Vein in Hematological Oncology Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100343
Enrollment
Unknown
Registered
2025-04-08
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological malignancies

Interventions

Routine PICC catheterization group:Retain routine PICC
Double Tunnel PICC Catheter Retention Group:Retain Double Tunnel PICC

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with hematologic tumors; 2. Patients who have a doctor's order for PICC catheter placement and have indications for upper arm venous catheterization; 3. Patients with normal coagulation function; 4. Patients who agree and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of venous thrombosis, surgery, and radiotherapy who intend to puncture blood vessels; 2. Patients with PICC indwelling time of less than 3 months; 3. Patients who are discharged from the hospital and lost to follow-up; 4. Patients with communication disorders and mental illness.

Design outcomes

Primary

MeasureTime frame
The operational quality during catheterization (including the success rate of one-time puncture and the success rate of one-time catheterization);Bleeding at the puncture site 48 hours after catheter;Frequency of catheter maintenance within two weeks and occurrence of complications after catheterization;

Countries

China

Contacts

Public ContactCheng Qiuqin

The First Affiliated Hospital of Zhejiang Chinese Medical University

390629008@qq.com+86 138 1910 9361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026